Effects of SSM, an extract from human type tubercle bacilli, on syngenic guinea pig tumors Haruo Nagae Institute of Vaccine Therapy for Tumors and Infectious Diseases, Nippon Medical School SSM (specific substance of Maruyama) is used widely in cancer therapy. Rats and mice have generally been used in basic research. In this study the author used guinea pigs because their skin properties are easier to monitor than those of rats and mice. The following experiments were performed on guinea pigs: 1) Potency as sensitizer and elicitor of delayed hypersensitivity.
Delayed-type hypersensitivity responses of sensitized guinea pigs with SSM. Guinea pigs had been sensitized with SSM (1 mg)-FIA 4 weeks previously. 20 pg/0.1 m/ of SSM was administered intradermally on the shaved flank. Skin reaction size was determined as a erythema diameter with caliper.
Fig. 2 Skin test data obtained in sensitized guinea
pigs with SSM or purified protein derivative (PPD). Guinea pigs were sensitized weekly from week 1 to week 3 with SSM (1 mg)-FIA and then 3 days after, 20 ,ug/0.1 ml of SSM was administered intradermally on the shaved flank. Skin reaction size was determined as a erythema diameter with caliper. Guinea pigs were sensitized weekly from week 1 to week 3 with SSM (1 mg)-FIA and these delayed skin reactivity of SSM were positive. The peritoneal exudate cells were harvested from sensitized guinea pigs 4 days after the injection liquid paraffin. gig/head SSM was injected intradermally on the tumor 6 times in a week for 3 weeks starting 7 days after tumor inoculation. Results indicate tumor weight on 29 days after innridatinn Fig. 4 Growth curve of U-1 carcinoma inoculated subcutaneously into Hartley/F guinea pigs. (Exp. 1) U-1 (5.5 x 107) was inoculated in guinea pigs. The largest and smallest diameters of tumors were measured at 3-or 4-day intervals and its mean diameter was recorded. 0-0, 100 gig/head of SSM was administered 6 times in a week.
Control (None) *p<0 .05 : as compared to the values obtained control group. (Exp. 2) U-1 (5 x 106) was inoculated in guinea pigs. The largest and smallest diameters of tumors were measured at 3-or 4-day intervals and its mean diameter was recorded . 0-0, 100 pg/head of SSM was administered 6 times in a week.
Saline was administered 6 times in a week as control. 6p<0 .05: as compared to the values obtained saline group. 3) U-1 (2.9 x 107) was inoculated subcutaneously on the flank of Hartley/F guinea pigs. 20 jig/ head SSM or saline was injected subcutaneously into the axilla 6 times in a week for 3 weeks starting 5 days after tumor inoculation. Results indicate tumor weight on 24 days after inoculation. Fig. 8 Growth curve of U-1 carcinoma inoculated subcutaneously into Hartley/F guinea pigs. (Exp. 3) U-1 (2.9 x 10') was inoculated in guinea pigs. The largest and smallest were measured at 3-or 4-day intervals and its mean diameter was recorded. 0-0, 20 pg/head of SSM was administered 6 times in a week.
Saline was administered 6 times in a week as control. *p<0 .01, *p<0.05: as compared to the values obtained saline group. (Exp. 4) U-1 (2.3 X 10') was inoculated in guinea pigs. The largest and smallest of tumors were measured at 3-or 4-day intervals and its mean diameter was recorded. 0-0, 20 gg/head of SSM was administered 6 times in a week. .z.-4" Saline was administered 6 times in a week as control. **p<0 .01, sp<0.05: as compared to the values obtained saline group. Science, 170, 637-639, 1970. 
